Recommendation ID

The committee recommends more research on:

  • the accuracy of PredictSURE IBD and IBDX tests in identifying people at high or low risk of following a severe course of Crohn's disease
  • how PredictSURE IBD and IBDX tests, when used alongside clinical features, affect clinical decisions about whether step-up or top-down treatment is offered
  • the clinical outcomes and costs resulting from a top-down treatment strategy compared with a step-up treatment strategy
  • how PredictSURE IBD and IBDX tests affect clinical outcomes once someone has been assigned to top-down or step-up treatment, considering the different pathways that children and adults may follow.
Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
PredictSURE IBD and IBDX to guide treatment of Crohn’s disease
Date issued
February 2022

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 28/02/2022